臺灣博碩士論文加值系統

中草藥產業自古以來一直是東方社會醫療體系中的重要產業之一，惟以西方的科學驗證中草藥時，一直無法有力地證明中草藥具有強大的醫療價值；自生物科技發展後，使得中草藥能夠透過生物科技的技術提出科學證據驗證醫療效果，讓中草藥的醫療價值逐漸提升，不僅各國積極地研究中草藥的特性，同時崇尚天然的風氣在全球興起，也讓中草藥的市場逐步擴大。
我國政府為增強台灣中草藥業的國際競爭力，自民國八十四年起推動一連串的政策發展中草藥業，但歷來有關中草藥業的文獻較少討論產業經營管理面的議題，就算在國內，也由於政府對於藥物管理的法令限制，而使得此產業活絡不起來，對於經營管理上的議題也就多有所侷限，因此在台灣熱烈發展中草藥業的同時，本研究希望從國際競爭力的角度深入地探討台灣中草藥業的發展，找出影響台灣中草藥業國際競爭力的因素及因素重要性的順序，並依此提出增強中草藥業國際競爭力的建議，以期有助於中草藥業的發展。
本研究以AHP為研究方法，並採用Porter的鑽石模型為理論基礎提出研究架構，透過文獻及訪談的資料整理出影響台灣中草藥國際競爭力的可能因素，再透過問卷收集產、官、學、研四個領域的專家意見，經由AHP的分析程序，找出影響台灣中草藥業因素的重要性順序；結果發現，市場因素(包含「全球消費者對天然產品的喜愛」(0.0629)、「國內消費者對健康及保健的重視」(0.0504)、「國內市場和國外市場需求的一致性」(0.0501)及「相對於西方醫學，提供另一種醫療方式的選擇」(0.0496))對我國中草藥業國際競爭力的影響最大；其次是政府在「培育優秀的人才」(0.0420)及「創造中草藥業有利的競爭環境」(0.0381)所扮演的角色；在廠商方面，「和國外廠商策略聯盟」(0.0364)、「廠商規模」(0.0338)以及「專利的取得」(0.0317)的重要性局於第七、第八及第十順位；相關與支援產業的子因素：「相關性產業具有國際競爭力」(0.0319)居於第九順位；在機遇方面，「國際認證制度的完善」(0.0317)及「生物科技的發展」(0.0312)分居第十一及十二的順位；最後，生產方面的因素則皆居於末座。
從研究結果當中，本研究提出增加台灣中草藥業國際競爭力的建議，對政府的建議是(一.)加強培育優秀的人才；(二.)營造中草藥業的競爭環境；(三.)加強中草藥醫療效果的深入研究；(四.)推廣中草藥；對中草藥廠商的建議是：(一.)加強市場導向；(二.)加強和國外廠商的合作和交流；(三.)加強國際認證及專利的取得。

Since the biotech developed, researchers have gradually brought up the scientific evidences to prove the medical effect of the Chinese-Herbal Medicine. The valuation of the Chinese-Herbal Medicine are rose recently and many researches are actively run to research the characteristics of the Chinese-Herbal Medicine in many countries. At the same time, by the advocating natural fashions is rising in the world, the international market of the Chinese-Herbal Medicine industry is gradually rising.
In order to heighten the international competitiveness of the Chinese-Herbal Medicine industry, Taiwan government has advanced a serious of policies to develop the Chinese-Herbal Medicine industry from 1995. Nevertheless, since the Chinese-Herbal Medicine industry developed, the management literatures of the Chinese-Herbal Medicine industry have less been discussed; furthermore, because of the degree limiting of Chinese Herbal Medicine, the development of the Chinese-Herbal Medicine industry is not prosperous. Now, the government so develops the Chinese-Herbal Medicine industry that the research hopes to discuss the development of the Chinese-Herbal Medicine industry from the international competitiveness, and find the factors of affecting International Competitiveness of Taiwan Chinese-Herbal Medicine industry to bring up several recommendations and help the development of Chinese-Herbal Medicine industry.
Analytical Hierarchy Process (AHP) is used in the research method and Porter’s diamond model is developed to the research framework. The possible factors affecting the international competitiveness are collected by literatures, interview and questionnaires by which the professional opinions are collected in the Industry, Government, the Academia, and the Research. By the analysis process of AHP, the factors affecting the international competitiveness can be found.
The result found, the market factors (including” Global consumer preference for natural products” (0.0629),” Domestic consumers place great importance on heath and health preservation” (0.0504), “Consistent consumer demand in both domestic and overseas market” (0.0501) and “In contrary to western medicine, it is an alternative therapeutic method” (0.0496) are the most powerful factors affecting international competitiveness of the Chinese-Herbal Medicine industry. The second powerful factors is the role of the government (including “Professional training” (0.0420) and “Professional data pool setup” (0.0381). From the Chinese-Herbal firms, “Strategy alliance with overseas form” (0.0364), “Firm’s scale” (0.0338)and “Patent acquisition” (0.0317) are sorted on seventh, eighth and tenth. From the related supporting industry, “Related industries possessing international competitiveness” is sorted on ninth. From chance, ” Good international license system” (0.0317)and “Biotech development” (0.0312) are sorted on eleventh and twelfth. Finally, from production, all factors are sorted on last.
From the result of the research, several recommendations are brought up to enhance the international competitiveness of the Chinese-Herbal Medicine industry. To the government, first, enhancing professional training; second, establishing the beneficial competitive environment for Chinese-Herbal Medicine industry; third, enhancing the in-depth studies of Chinese-Herbal Medicine; finally, promoting the Chinese-Herb al Medicine concept. To the Chinese-Herbal Medicine firms, first, enhancing the market orientation; second, enhancing the cooperation and communication with foreign medical firms; finally enhancing to get the International certification and patent.

ABSTRACT IN CHINESE i
ABSTRACT IN ENGLISH iii
ACKNOWLEGEMENT vi
LIST OF TABLES ix
LIST OF ILLUSTATION x
CHAPTER
I INTRODUCTION 1
Research Background 1
Research Motives 4
Research Objective 5
II LITERATURE REVIEW 7
Competition, Competitive Advantage, and International Competitiveness 7
Model of International Competitive Advantage 10
Analytical Hierarchy Process 19
III RESEARCH DESIGN 30
Research Structure 30
AHP Study Procedure 32
Introduction of Chinese-Herbal Industry 38
Research Design 48
Ⅳ DATA ANALYSIS 59
Questionnaire Analysis in First Step 59
The Sequence of Importance 59
The Formal Hierarchy of AHP 61
Questionnaire Analysis in Second Step 63
The Analysis of Each Hierarchy 63
V CONCLUSION AND RECOMMEDATION 76
A Contrast with Past Relative Researches 76
Research Conclusion 78
Research Recommendation 80
Study Limitation and Recommendation 83
BIBLIOGRAPHY 86

表目錄 III
圖目錄 IV
第一章 緒論 1
第一節 研究背景與動機 1
第二節 研究目的 5
第三節 研究流程 6
第二章 文獻探討 7
第一節 競爭、競爭優勢與國際競爭力 7
第二節 國際競爭優勢的模型 10
第三節 層級分析法 20
第三章 研究設計 31
第一節 研究架構 31
第二節 AHP的研究程序 32
第三節 中草藥業的介紹 39
第四節 研究設計 48
第四章 資料分析 60
第一節 第一階段的問卷分析 60
第二節 第二階段的問卷分析 65
第五章 結論與建議 81
第一節 與過去相關研究結果之比對 81
第二節 研究結論 83
第三節 研究建議 85
第四節 研究限制與後續研究建議 88
參考文獻 90
附錄 96

中草藥產業技術教學資源中心，中草藥產業技術與研發，台北：中草藥產業技術教學資源中心，民92年。
方世杰，國際競爭力的探討，科學發展月刊232，行政院國科會，民84 年。
李逢春，生物科技發展下台灣製藥產業之經營現況與策略，元智大學管理研究所碩士論文，2003。
林永裕，台灣保健食品暨中草藥產業競爭優勢之研究，中山大學國際高階經營管理碩士班碩士論文，2003。
波特，國家競爭優勢(上)(下)，台北：天下文化出版有限公司，1996。
范慧宜，我國高科技產業國際競爭優勢之實證研究─以LCD為例，中國文化大學國際企業管理研究所碩士論文，2000。
徐慧芬，以鑽石模式建立國際港埠競爭力評估準則之研究，交通大學運輸工程與管理學系碩士論文，民88年。
莊晏詞，論中草藥產業發展及法制規範-以美國與台灣之法制分析比較為重心，逢甲大學財經法律研究所碩士論文，2006。
財團法人生物技術開發中心，醫藥產業年鑑2005，台北：財團法人生物技術開發中心，2005。
財團法人生物技術開發中心，醫藥產業年鑑2006，台北：財團法人生物技術開發中心，2006。
財團法人生物技術開發中心，中草藥產業年鑑2004，台北：財團法人生物技術開發中心，2004。
陳永鑫，台灣新中藥產業價值鏈中價值活動的SWOT分析與發展方向之研究，政治大學經營管理碩士學程碩士論文，2002。
許榮淑，從中藥品質管制探討我國中藥產業競爭策略之研究，中山大學國際高階經營管理碩士班碩士論文，2003。
褚志鵬，層級分析法，東華大學企業管理學系，2003。
黃振廷，利用分析層級程序法探討台灣中草藥製造業之關鍵成功因素，中央大學資訊管理研究所碩士論文，2002。
楊渝幸，中草藥生物科技專利保護之研究，中國文化大學法律學研究所碩士論文，2006。
經濟部技術處，中草藥產業現況與趨勢，台北：財團法人生物技術開發中心，民90年。
經濟部技術處，2003產業白皮書，台北：經濟部技術處，2003。
蔡坤達，影響我國生物科技產業國際競爭力相關因素之研究，國立成功大學企業管理研究所碩士班論文，2002。
劉尚志，智財權規範與中草藥技術發展之研究，中醫藥年報第23期第1冊，2005。
廖威閎，台灣中草藥產業經營策略，台灣大學國際企業學研究所，2005。
鄭振源，計畫評估-方法與應用，台北：海洋大學運籌規劃與管理研究中心，2002。
譚大純，產業國際競爭力之衡量：以Poter鑽石模式為基礎之量表建構與跨國實證，台北：成功大學企業管理研究所未出版博士論文，民87年。

Boltho A. “The Assessment: International Competitiveness.” Oxford Review of Economic Policy 12, no.3 (1996): 1-16.
Bellak, C. J. and A. Weiss “A note on the Austrian diamond.” Management International Review 33, (1993): 109-118.
Bridwell, L. and J. K. Chun. “An Analysis of the Computer Industry in China and Taiwan Using Michael Porter’s Determinants of National Competitive Advantage.” Competitiveness Review 15, no.2 (1993): 116-120.
Cartwright, W. R. “Multiple Linked Diamonds and the International Competitiveness of Export-Dependent Industries: The New Zealand Experience.” Management International Review 33, no.2 (1993): 55-70.
Dunning, J. H. ”Internationalizing Porter's Diamond.” Management International Review 1993 Special 33, no.2 (1993): 7-16.
Francis, A. “The Process of National Industrial Regeneration and Competitiveness.” Strategic Management Journal, Winter92 Special 13, no.8 (1992): 61-78.
Francis, A. P. “The concept of Competitiveness.” The Competitiveness of European Industry, (1989): 5-20.
Grant, R.M. “The Resource-Based Theory of Competitive Advantage: Implications for Strategy Formulation.” California Management Review 33, no.3 Spring, (1991): 114-135.
Grein A. F. and C. S. Craig. “Economic Performance Over Time: Does Porter's Diamond Hold at the Nation Level?” International Executive 38, no.3 (1996): 303-322.
Griffiths, A. and R. F. Zammuto. “Institutional Governance Systems and Variations in National Competitive Advantage: An Integrative Framework.” Academy of Management Review, Oct2005 30, no.4 (2005): 823-842.
Hodgetts, R. ”Porter’s Diamond Framework in a Mexican Context.” Management International Review 33, no.2 (1993): 41-54.
Kogut, B. “Managing the Internationalization Process: The Swedish Case.” Organization Studies 14, no.1 (1993): 132-134.
Moon, H. C., A. M. Rugman, and A. Verbeke “A Generalized Double Diamond Approach to the Global Competitiveness of Korea and Singapore.” International Business Review, Apr98 7, no.2 (1998): 135-150.
Porter, M. E. Competitive Advantage of Nations, New York: Free Press, 1990.
Porter, M. E. Competitive Advantage: Creating and Sustaining Superior Performance, New York: Free Press, 1985.
Rugman A. M. and A. Verbeke. “Foreign Subsidiaries and Multinational Strategic Management: An Extension and Correction of Porter's Single Diamond Framework.” Management International Review 33, no.2 (1993): 71-84.
Rugman, A. M. and J. R. D'Cruz. “The 'Double Diamond' Model of International Competitiveness: the Canadian Experience.” Management International Review, 1993 Special 33, no.2 (1993): 17-39.
Rhonda A.H., E. Sevgi, and M. D. Joshua. “An Experiment on the Consistency of Aggregated Comparison Matrices in AHP.” European Journal of Operational Research, no.171, (2006): 290-295.
Roper-Low, G. C. and J. A. Sharp. “The Analytic Hierarchy Process and Its Application to an Information Technology Decision.” Journal of Operational Research Society, no.1, (1990): 49-60.
Shanteau, J. “Competence in Experts: The Role of Task Characteristics.” Organizational Behavior and Human Decision Process, no.53, (1992): 252-266.
Saaty, T. L. “Axiomatic Foundation of the Analytic Hierarchy Process.” Management Science 32, no.7 (1986): 841-855.
Saaty, T. L. “Decision-Making with the AHP: Why is the Principal Eigenvector Necessary.” European Journal of Operational Research 145, no.1 (2003): 85-92.
Saaty, T. L. “How to Make a Decision: The Analytic Hierarchy Process.” Interfaces 24, no.6 (1994): 19-43.
Saaty, T. L. and Y. Wind. “Marketing Applications of the Analytic Hierarchy Process.” Management Science, July80 26, no.7 (1980): 641-658.
Saaty, T. L., P. C. Rogers, and R. Pell “Portfolio Selection through Hierarchies.” Journal of Portfolio Management 6, no.3 (1980): 18-23.
Saaty, T. L. and L. G .Vargas. “Diagnosis with Department Symptoms : Bayes Theorem and the Analytic Hierarchy Process.” Operations Research 46, (1997): 491-502.
Saaty, T. L. and L. G. Vargas. “Uncertainty and Rank Order in the Analytic Hierarchy Process.” European Journal of Operational Research, Oct87 32, no.1 (1987): 107-117.
Vickner, S. S. and S. P. Davies. “Estimating Strategic Price Response Using Cointegration Analysis: The Case of the Domestic Black and Herbal Tea Industries.” Agribusiness 18, no.2 (2002): 131-144.
VanDen, B. F., P. A .Van, and M. E. Porter ”The Competitive Advantage of European Nations: The Impact of National Culture ─ A Missing Element in Porter's Analysis?, A Note on Culture and Competitive Advantage: Response to van den Bosch and van Prooijen.” European Management Journal 10, no.2 (1992): 173-178.
VanDen, B. F., A. J. Frans, and A. P. DeMan. ”Government's Impact on the Business Environment and Strategic Management.” Journal of General Managemen 19, no.3 (1994): 50-59.
Vargas, L. G. “An overview of the Analytic Hierarchy Process and its applications.” European Journal of Operational Research 48, no.1 (1990): 2-8.
Wilke, M. “AHP Move into Herbal Remedies Market.” Advertising Age, no.68, (1997).